AAAAAA
Results:
1-17
|
Results: 17
Authors:
VOKES EE
MAUER AM
Citation: Ee. Vokes et Am. Mauer, MULTIMODALITY THERAPY FOR ESOPHAGEAL CANCER - AN EMERGING ROLE, The cancer journal from Scientific American, 4(4), 1998, pp. 226-229
Authors:
MASTERS GA
MAUER AM
HOFFMAN PC
WYKA D
SAMUELS BL
KRAUSS SA
WATSON S
GOLOMB H
VOKES EE
Citation: Ga. Masters et al., A PHASE I-II STUDY OF PACLITAXEL, IFOSFAMIDE, AND VINORELBINE WITH FILGRASTIM (RHG-CSF) SUPPORT IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 9(6), 1998, pp. 677-680
Authors:
MAUER AM
VOGELZANG NJ
JANISH L
MANI S
SAMARA E
RATAIN MJ
Citation: Am. Mauer et al., PHASE-I STUDY OF CEP-2563 DIHYDROCHLORIDE (CEP-2563), A TYROSINE KINASE INHIBITOR, IN PATIENTS WITH SOLID TUMORS, Annals of oncology, 9, 1998, pp. 489-489
Authors:
MAUER AM
MASTERS GA
HARAF DJ
HOFFMAN PC
WATSON SM
GOLOMB HM
VOKES EE
Citation: Am. Mauer et al., PHASE-I STUDY OF DOCETAXEL WITH CONCOMITANT THORACIC RADIATION-THERAPY, Journal of clinical oncology, 16(1), 1998, pp. 159-164
Authors:
VOKES EE
MAUER AM
HOFFMAN PC
HARAF DJ
Citation: Ee. Vokes et al., COMBINED-MODALITY THERAPY IN NONSMALL CELL LUNG AND ESOPHAGEAL CANCER- A PHASE-I DOSE-ESCALATION STUDY OF DOCETAXEL WITH CONCURRENT RADIOTHERAPY, Seminars in oncology, 25(3), 1998, pp. 28-32
Authors:
VOKES EE
MASTERS GA
MAUER AM
HOFFMAN PC
WATSON S
GOLOMB HM
Citation: Ee. Vokes et al., IFOSFAMIDE-BASED 3-DRUG COMBINATION REGIMENS IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(1), 1998, pp. 19-22
Authors:
HAASE GM
MAUER AM
REAMAN GH
Citation: Gm. Haase et al., SURVIORSHIP IN CHILDHOOD-CANCER A CASE STATEMENT FOR ENHANCEMENT OF THE ROLE OF THE AMERICAN-CANCER-SOCIETY, Cancer, 83(4), 1998, pp. 821-823
Authors:
VOKES EE
MASTERS GA
MAUER AM
HARAF DJ
HOFFMAN PC
GOLOMB HM
Citation: Ee. Vokes et al., CLINICAL-STUDIES OF DOCETAXEL (TAXOTERE) AND CONCOMITANT CHEST THERAPY, Seminars in oncology, 24(4), 1997, pp. 26-29
Authors:
VOKES EE
MAUER AM
HOFFMAN PC
MASTERS G
WATSON S
GOLOMB HM
Citation: Ee. Vokes et al., PACITAXEL CARBOPLATIN PLUS IFOSFAMIDE IN NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 24(4), 1997, pp. 67-69
Authors:
MULCAHY GM
GOGGINS M
WILLIS D
DECKER RA
LUCE MC
PARSONS R
MARKOWITZ S
NAROD SA
HOLT JT
PAGE DL
MAUER AM
THOR A
Citation: Gm. Mulcahy et al., PATHOLOGY AND GENETIC TESTING - WORKSHOP NO.6, Cancer, 80(3), 1997, pp. 636-648
Authors:
MAUER AM
Citation: Am. Mauer, CHANGING OF THE GUARD, Medical and pediatric oncology, 27(6), 1996, pp. 3-3
Authors:
LAURIA MM
HOCKENBERRYEATON M
PAWLETKO TM
MAUER AM
Citation: Mm. Lauria et al., PSYCHOSOCIAL PROTOCOL FOR CHILDHOOD-CANCER - A CONCEPTUAL-MODEL, Cancer, 78(6), 1996, pp. 1345-1356
Authors:
MILLER AA
MAUER AM
TOLLEY EA
Citation: Aa. Miller et al., DOSING OF ORAL ETOPOSIDE NORMALIZED FOR BODY-SURFACE AREA, Cancer investigation, 13(5), 1995, pp. 487-491
Authors:
NIELL HB
MAUER AM
RADEMACHER D
Citation: Hb. Niell et al., CYTOTOXIC EFFECTS OF ALPHA-INTERFERON AND GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR IN HUMAN BLADDER-TUMOR CELL-LINES, Urological research, 22(4), 1994, pp. 247-250
Authors:
CHELSKY MJ
ROSEN SI
KNIGHT LC
MAUER AM
HANNO PM
RUGGIERI MR
Citation: Mj. Chelsky et al., BLADDER PERMEABILITY IN INTERSTITIAL CYSTITIS IS SIMILAR TO THAT OF NORMAL VOLUNTEERS - DIRECT MEASUREMENT BY TRANSVESICAL ABSORPTION OF (99M)TECHNETIUM-DIETHYLENETRIAMINEPENTAACETIC ACID - REPLY, The Journal of urology, 152(6), 1994, pp. 2106-2106
Authors:
MILLER AA
TOLLEY EA
NIELL HB
GRIFFIN JP
MAUER AM
Citation: Aa. Miller et al., PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1179-1188
Authors:
JENNINGS LK
WHITE MM
SAUER CM
MAUER AM
ROBERTSON JT
Citation: Lk. Jennings et al., COCAINE-INDUCED PLATELET DEFECTS, Stroke, 24(9), 1993, pp. 1352-1359
Risultati:
1-17
|